US Stock MarketDetailed Quotes

Kezar Life Sciences (KZR)

Watchlist
  • 7.290
  • -0.040-0.55%
Close Apr 27 16:00 ET
53.74MMarket Cap-0.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kezar Life Sciences (KZR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.23%-51.78M
28.90%-11.96M
43.81%-9.83M
24.87%-12.8M
24.81%-17.19M
9.10%-74.21M
11.35%-16.83M
13.42%-17.49M
21.15%-17.03M
-9.60%-22.86M
Net income from continuing operations
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Operating gains losses
--428K
--150K
----
----
----
----
----
----
----
----
Depreciation and amortization
-13.75%897K
-32.05%176K
-12.69%227K
-6.90%243K
-3.46%251K
-2.44%1.04M
-7.50%259K
-6.47%260K
4.82%261K
0.39%260K
Other non cash items
74.53%466K
208.11%228K
-42.19%37K
-35.38%42K
148.44%159K
12.18%267K
19.35%74K
10.34%64K
10.17%65K
8.47%64K
Change In working capital
-315.62%-5.4M
-140.57%-271K
-246.83%-787K
-228.04%-1.21M
9.10%-3.14M
-127.62%-1.3M
-92.00%668K
123.21%536K
374.87%945K
-125.57%-3.45M
-Change in prepaid assets
469.85%1.91M
-65.39%951K
90.52%-432K
-11.60%2.1M
-201.27%-714K
-90.65%335K
1,129.21%2.75M
-384.04%-4.56M
267.85%2.38M
-114.82%-237K
-Change in payables and accrued expense
-133.25%-7.34M
61.66%-590K
-128.42%-426K
-2,709.28%-2.73M
-19.54%-3.6M
-149.57%-3.15M
-260.48%-1.54M
-48.93%1.5M
-108.82%-97K
-322.39%-3.01M
-Change in other current assets
-24.06%2.42M
----
----
--0
1,752.13%1.74M
164.62%3.18M
----
----
30.73%-1.02M
102.13%94K
-Change in other working capital
-43.14%-2.39M
18.11%-3.05M
-32.03%1.81M
-85.80%-589K
-90.24%-565K
-450.83%-1.67M
-166.76%-3.72M
146.48%2.67M
-328.38%-317K
-343.28%-297K
Cash from discontinued investing activities
Operating cash flow
30.23%-51.78M
28.90%-11.96M
43.81%-9.83M
24.87%-12.8M
24.81%-17.19M
9.10%-74.21M
11.35%-16.83M
13.42%-17.49M
21.15%-17.03M
-9.60%-22.86M
Investing cash flow
Cash flow from continuing investing activities
14.96%92.46M
117.37%51.61M
-34.70%15.71M
-6.70%11.4M
-32.66%13.74M
5.76%80.43M
-14.83%23.74M
29.54%24.06M
-7.48%12.22M
24.51%20.41M
Net PPE purchase and sale
489.66%113K
1,118.18%112K
150.00%9K
--0
---8K
98.39%-29K
-1,000.00%-11K
86.26%-18K
--0
--0
Net investment purchase and sale
14.78%92.35M
116.80%51.5M
-34.78%15.7M
-6.70%11.4M
-32.62%13.75M
3.35%80.46M
-14.79%23.76M
28.72%24.08M
-16.21%12.22M
22.29%20.41M
Cash from discontinued investing activities
Investing cash flow
14.96%92.46M
117.37%51.61M
-34.70%15.71M
-6.70%11.4M
-32.66%13.74M
5.76%80.43M
-14.83%23.74M
29.54%24.06M
-7.48%12.22M
24.51%20.41M
Financing cash flow
Cash flow from continuing financing activities
-10,376.70%-10.59M
-14,370.21%-6.71M
-1.31M
-2,366.07%-1.27M
-1.3M
-83.86%103K
-20.34%47K
0
-85.34%56K
0
Net issuance payments of debt
---10.65M
---6.74M
---1.31M
---1.3M
---1.3M
--0
--0
--0
--0
--0
Net common stock issuance
-36.89%65K
-36.17%30K
--0
----
----
-83.86%103K
-20.34%47K
--0
-85.34%56K
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
-83.86%103K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-10,376.70%-10.59M
-14,370.21%-6.71M
---1.31M
-2,366.07%-1.27M
---1.3M
-83.86%103K
-20.34%47K
--0
-85.34%56K
--0
Net cash flow
Beginning cash position
17.63%41.75M
11.70%38.94M
21.54%34.37M
12.02%37M
17.63%41.75M
-12.27%35.49M
31.55%34.86M
0.59%28.28M
-8.57%33.03M
-12.27%35.49M
Current changes in cash
376.36%30.1M
372.91%32.94M
-30.29%4.58M
43.96%-2.67M
-93.64%-4.75M
227.37%6.32M
-22.23%6.97M
513.48%6.57M
40.62%-4.76M
43.13%-2.45M
Effect of exchange rate changes
144.44%28K
--0
-156.25%-9K
966.67%32K
171.43%5K
-3,050.00%-63K
-297.37%-75K
169.57%16K
160.00%3K
41.67%-7K
End cash Position
72.17%71.88M
72.17%71.88M
11.70%38.94M
21.54%34.37M
12.02%37M
17.63%41.75M
17.63%41.75M
31.55%34.86M
0.59%28.28M
-8.57%33.03M
Free cash flow
30.25%-51.79M
28.95%-11.96M
43.87%-9.83M
24.87%-12.8M
24.77%-17.2M
11.04%-74.24M
11.30%-16.84M
13.91%-17.51M
25.87%-17.03M
-8.06%-22.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.23%-51.78M28.90%-11.96M43.81%-9.83M24.87%-12.8M24.81%-17.19M9.10%-74.21M11.35%-16.83M13.42%-17.49M21.15%-17.03M-9.60%-22.86M
Net income from continuing operations 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Operating gains losses --428K--150K--------------------------------
Depreciation and amortization -13.75%897K-32.05%176K-12.69%227K-6.90%243K-3.46%251K-2.44%1.04M-7.50%259K-6.47%260K4.82%261K0.39%260K
Other non cash items 74.53%466K208.11%228K-42.19%37K-35.38%42K148.44%159K12.18%267K19.35%74K10.34%64K10.17%65K8.47%64K
Change In working capital -315.62%-5.4M-140.57%-271K-246.83%-787K-228.04%-1.21M9.10%-3.14M-127.62%-1.3M-92.00%668K123.21%536K374.87%945K-125.57%-3.45M
-Change in prepaid assets 469.85%1.91M-65.39%951K90.52%-432K-11.60%2.1M-201.27%-714K-90.65%335K1,129.21%2.75M-384.04%-4.56M267.85%2.38M-114.82%-237K
-Change in payables and accrued expense -133.25%-7.34M61.66%-590K-128.42%-426K-2,709.28%-2.73M-19.54%-3.6M-149.57%-3.15M-260.48%-1.54M-48.93%1.5M-108.82%-97K-322.39%-3.01M
-Change in other current assets -24.06%2.42M----------01,752.13%1.74M164.62%3.18M--------30.73%-1.02M102.13%94K
-Change in other working capital -43.14%-2.39M18.11%-3.05M-32.03%1.81M-85.80%-589K-90.24%-565K-450.83%-1.67M-166.76%-3.72M146.48%2.67M-328.38%-317K-343.28%-297K
Cash from discontinued investing activities
Operating cash flow 30.23%-51.78M28.90%-11.96M43.81%-9.83M24.87%-12.8M24.81%-17.19M9.10%-74.21M11.35%-16.83M13.42%-17.49M21.15%-17.03M-9.60%-22.86M
Investing cash flow
Cash flow from continuing investing activities 14.96%92.46M117.37%51.61M-34.70%15.71M-6.70%11.4M-32.66%13.74M5.76%80.43M-14.83%23.74M29.54%24.06M-7.48%12.22M24.51%20.41M
Net PPE purchase and sale 489.66%113K1,118.18%112K150.00%9K--0---8K98.39%-29K-1,000.00%-11K86.26%-18K--0--0
Net investment purchase and sale 14.78%92.35M116.80%51.5M-34.78%15.7M-6.70%11.4M-32.62%13.75M3.35%80.46M-14.79%23.76M28.72%24.08M-16.21%12.22M22.29%20.41M
Cash from discontinued investing activities
Investing cash flow 14.96%92.46M117.37%51.61M-34.70%15.71M-6.70%11.4M-32.66%13.74M5.76%80.43M-14.83%23.74M29.54%24.06M-7.48%12.22M24.51%20.41M
Financing cash flow
Cash flow from continuing financing activities -10,376.70%-10.59M-14,370.21%-6.71M-1.31M-2,366.07%-1.27M-1.3M-83.86%103K-20.34%47K0-85.34%56K0
Net issuance payments of debt ---10.65M---6.74M---1.31M---1.3M---1.3M--0--0--0--0--0
Net common stock issuance -36.89%65K-36.17%30K--0---------83.86%103K-20.34%47K--0-85.34%56K--0
Proceeds from stock option exercised by employees ---------------------83.86%103K----------------
Cash from discontinued financing activities
Financing cash flow -10,376.70%-10.59M-14,370.21%-6.71M---1.31M-2,366.07%-1.27M---1.3M-83.86%103K-20.34%47K--0-85.34%56K--0
Net cash flow
Beginning cash position 17.63%41.75M11.70%38.94M21.54%34.37M12.02%37M17.63%41.75M-12.27%35.49M31.55%34.86M0.59%28.28M-8.57%33.03M-12.27%35.49M
Current changes in cash 376.36%30.1M372.91%32.94M-30.29%4.58M43.96%-2.67M-93.64%-4.75M227.37%6.32M-22.23%6.97M513.48%6.57M40.62%-4.76M43.13%-2.45M
Effect of exchange rate changes 144.44%28K--0-156.25%-9K966.67%32K171.43%5K-3,050.00%-63K-297.37%-75K169.57%16K160.00%3K41.67%-7K
End cash Position 72.17%71.88M72.17%71.88M11.70%38.94M21.54%34.37M12.02%37M17.63%41.75M17.63%41.75M31.55%34.86M0.59%28.28M-8.57%33.03M
Free cash flow 30.25%-51.79M28.95%-11.96M43.87%-9.83M24.87%-12.8M24.77%-17.2M11.04%-74.24M11.30%-16.84M13.91%-17.51M25.87%-17.03M-8.06%-22.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -